ONLINE DATABASE SEARCH - HIV-LS-331-MEMO
1. 47870 HIV-LS-331; PUBMED-HIV-9/19/2005
Computational Studies and Drug Design for HIV-1 Reverse Transcriptase Inhibitors of 3',4'-di-O-(S)-camphanoyl-(+)-cis-Khellactone (DCK) Analogs
Chen, HF, Fan, BT, Zhao, CY, Xie, L, Zhao, CH, Zhou, T, Lee, KH, and Allaway, G
J Comput Aided Mol Des 2005. 19(4): 243-58
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16163451&dopt=abstract
2. 47871 HIV-LS-331; PUBMED-HIV-9/19/2005
Quantitative Structure-activity Relationship Analysis of Pyridinone HIV-1 Reverse Transcriptase Inhibitors using the k Nearest Neighbor Method and QSAR-based Database Mining
Medina-Franco, JL, Golbraikh, A, Oloff, S, Castillo, R, and Tropsha, A
J Comput Aided Mol Des 2005. 19(4): 229-42
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16163450&dopt=abstract
3. 47872 HIV-LS-331; SCIFINDER-HIV-9/15/2005
Preparation of PNA-neamine conjugates as antiviral agents
Decout, Jean-Luc, Pandey, Virendra N, and Riguet, Emmanuel
PATENT: WO 2005060573 ISSUE DATE: 20050707
APPLICATION: 2004 PP: 67 pp.
ASSIGNEE: (University of Medicine and Dentistry of New Jersey, USA and Universite Joseph Fourier)
4. 47873 HIV-LS-331; PUBMED-HIV-9/19/2005
Synthesis, Anti-HIV Activity, and Metabolic Stability of New Alkenyldiarylmethane HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Deng, BL, Hartman, TL, Buckheit, RW Jr, Pannecouque, C, De, Clercq E, Fanwick, PE, and Cushman, M
J Med Chem 2005. 48(19): 6140-6155
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16162014&dopt=abstract
5. 47874 HIV-LS-331; PUBMED-HIV-9/19/2005
Naturally derived anti-HIV agents
Asres, K, Seyoum, A, Veeresham, C, Bucar, F, and Gibbons, S
Phytother Res 2005. 19(7): 557-581
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16161055&dopt=abstract
6. 47875 HIV-LS-331; PUBMED-HIV-9/19/2005
Targeting HIV protease: From peptidomimetics to non-peptide inhibitors
Gago, F
IDrugs 1999. 2(4): 309-20
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16158350&dopt=abstract
7. 47876 HIV-LS-331; PUBMED-HIV-9/19/2005
Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: Effects of viral diversity, target cell and receptor density
Willey, S, Peters, PJ, Sullivan, WM, Dorr, P, Perros, M, and Clapham, PR
Antiviral Res 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16157392&dopt=abstract
8. 47877 HIV-LS-331; PUBMED-HIV-9/19/2005
A novel heme-containing protein with anti-HIV-1 activity from skin secretions of Bufo andrewsi
Zhao, Y, Jin, Y, Wang, JH, Wang, RR, Yang, LM, Lee, WH, Zheng, YT, and Zhang, Y
Toxicon 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16157359&dopt=abstract
9. 47878 HIV-LS-331; SCIFINDER-HIV-9/15/2005
Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors
Westby, Mike, Nakayama, Grace R, Butler, Scott L, and Blair, Wade S
Antiviral Research 2005. 67(3): 121-140
10. 47879 HIV-LS-331; SCIFINDER-HIV-9/15/2005
New and improved 5,10-dihydrobenzo[b][1,8]naphthyridine-N-oxides as the next generation NNRTI's with better activity profiles against clinically relevant HIV-1 mutants
Srivastava, Anurag S, Tarby, Christine M, Johnson, Barry M, Rajagopal, Bhakthavatchalam, Curry, Matthew, Lin, Qiyan, Wang, Haisheng, Cocuzza, Anthony J, Bilder, Donna M, McHugh, Robert J, Patel, Mona, Bacheler, Lee T, Diamond, Sharon, Jeffrey, Susan, Klabe, Ronald M, Cordova, Beverly C, Garber, Sena, Logue, Kelly, Erickson-Viitanen, Susan, Trainor, George L, and Rodgers, James D
Abstracts of Papers, 230th ACS National Meeting, Washington, DC, United States, Aug. 28-Sept. 1, 2005 2005.: MEDI-181
11. 47880 HIV-LS-331; PUBMED-HIV-9/19/2005
Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection
Bianchi, E, Finotto, M, Ingallinella, P, Hrin, R, Carella, AV, Hou, XS, Schleif, WA, Miller, MD, Geleziunas, R, and Pessi, A
Proc Natl Acad Sci U S A 2005. 102(36): 12903-8
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16129831&dopt=abstract
12. 47881 HIV-LS-331; SCIFINDER-HIV-9/15/2005
Inhibiting replication of a retrovirus, such as human immunodeficiency virus (HIV), through modulation of HIV Vif- or Vpu-mediated ubiquitylation of host cell proteins, such as CEM15 or CD4
Payan, Donald G and Jenkins, Yonchu
PATENT: WO 2005047476 ISSUE DATE: 20050526
APPLICATION: 2004 PP: 109 pp.
ASSIGNEE: (Rigel Pharmaceuticals, Inc. USA
13. 47882 HIV-LS-331; SCIFINDER-HIV-9/15/2005
Aminopyrimidinimino isatin analogues: Design and synthesis of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum anti-microbial properties
Sriram, Dharmarajan, Bal, Tanushree Ratan, and Yogeeswari, Perumal
Medicinal Chemistry 2005. 1(3): 277-285
14. 47883 HIV-LS-331; SCIFINDER-HIV-9/15/2005
Lowering the Dose of Hydroxyurea Minimizes Toxicity and Maximizes Anti-HIV Potency
Lori, Franco, Pollard, RB, Whitman, L, Bakare, N, Blick, G, Shalit, P, Foli, A, Peterson, D, Tennenberg, A, Schrader, S, Rashbaum, B, Farthing, C, Herman, D, Norris, D, Greiger, P, Frank, I, Groff, A, Lova, L, Asmuth, D, and Lisziewicz, J
AIDS Research and Human Retroviruses 2005. 21(4): 263-272
15. 47884 HIV-LS-331; PUBMED-HIV-9/19/2005
Long-Term Inhibition of HIV-1 Infection in Primary Hematopoietic Cells by Lentiviral Vector Delivery of a Triple Combination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy
Li, MJ, Kim, J, Li, S, Zaia, J, Yee, JK, Anderson, J, Akkina, R, and Rossi, JJ
Mol Ther 2005.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16115802&dopt=abstract
16. 47885 HIV-LS-331; SCIFINDER-HIV-9/15/2005
Syntheses and anti-viral properties of N-6 substituted derivatives of L-like 4'-deoxy-5'-noraristeromycin and oxyamino and hydroxylamino carbanucleosides
Serbessa, Tesfaye, Roy, Atanu, Yang, Minmin, and Schneller, Stewart W
229th ACS National Meeting 2005. 229: MEDI-341
17. 47886 HIV-LS-331; SCIFINDER-HIV-9/15/2005
Preparation of pyrido[1,2-a]pyrazine-1,8-dione derivatives as HIV integrase inhibitors
Miyazaki, Susumu, Katoh, Susumu, Adachi, Kaoru, Isoshima, Hirotaka, Kobayashi, Satoru, Matsuzaki, Yuji, Watanabe, Wataru, Yamataka, Kazunobu, Kiyonari, Shinichi, and Wamaki, Shuichi
PATENT: WO 2005016927 ISSUE DATE: 20050224
APPLICATION: 2004 PP: 355 pp.
ASSIGNEE: (Japan Tobacco Inc., Japan
18. 47887 HIV-LS-331; WOS-HIV-9/11/2005
Darunavir - Anti-HIV agent HIV protease inhibitor
Sorbera, LA, Castaner, J, and Bayes, M
DRUGS OF THE FUTURE 2005. 30(5): 441-449, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231410500001
19. 47888 HIV-LS-331; WOS-HIV-9/11/2005
Etravirine - Anti-HIV agent reverse transcriptase inhibitor
Davies, SL, Castaner, J, Silvestre, JS, and Bayes, M
DRUGS OF THE FUTURE 2005. 30(5): 462-468, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231410500003
20. 47889 HIV-LS-331; WOS-HIV-9/11/2005
Maraviroc - Anti-HIV agent viral entry inhibitor chemokine CCR5 antagonist
Ginesta, JB, Castaner, J, Bozzo, J, and Bayes, M
DRUGS OF THE FUTURE 2005. 30(5): 469-477, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231410500004
21. 47890 HIV-LS-331; WOS-HIV-9/18/2005
L-carnitine, immunomodulation, and human immunodeficiency virus (HIV)-related disorders
Alesci, S, Gerschenson, M, and Ilias, L
MONATSHEFTE FUR CHEMIE 2005. 136(8): 1493-1500, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231538500019
22. 47891 HIV-LS-331; WOS-HIV-9/18/2005
The synthetic peptide derived from the NH2-terminal extracellular region of an orphan G protein-coupled receptor, GPR1, preferentially inhibits infection of X4 HIV-1
Jinno-Oue, A, Shimizu, N, Soda, Y, Tanaka, A, Ohtsuki, T, Kurosaki, D, Suzuki, Y, and Hoshino, H
JOURNAL OF BIOLOGICAL CHEMISTRY 2005. 280(35): 30924-30934, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231487800034
23. 47892 HIV-LS-331; WOS-HIV-9/18/2005
New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: Synthesis and biological activity
Normand-Bayle, M, Benard, C, Zouhiri, F, Mouscadet, JF, Leh, H, Thomas, CM, Mbemba, G, Desmaele, D, and d'Angelo, J
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2005. 15(18): 4019-4022, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231493400007
24. 47893 HIV-LS-331; WOS-HIV-9/18/2005
Effect of change in nucleoside structure on the activation and antiviral activity of phosphoramidate derivatives
Venkatachalam, TK, Samuel, P, Qazi, S, and Uckun, FM
BIOORGANIC & MEDICINAL CHEMISTRY 2005. 13(18): 5408-5423, 16
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000231493800008